Background: Ingenol derivatives have received constant and multidisciplinary attention on account of their pleiotropic pattern of biological activity. This includes activation of protein kinase C (PKC), tumour-promotion, anticancer, and anti-HIV properties, and the possibility of dissecting co-cancerogenic and clinically useful activities has been demonstrated. Certain ingenol esters show powerful anticancer activity, and a structure^activity relationship model to discriminate between their apoptotic and non-apoptotic properties has been developed.
Introduction
The use of spurges (Euphorbia spp.) to treat tumours is well documented in Greek and Roman medical literature [1] , and modern studies have shown that these plants are still employed to treat cancerous conditions in traditional medicine in many areas of the world [1] . These historical and ethnobotanical clues have been backed up by the discovery of the powerful antineoplastic activity of ingenol 3,20-dibenzoate (IDB) [2] , and certain semi-synthetic ingenoids are among the most powerful cytotoxic agents known, with an IC 50 in the sub-nanomolar range [3] . Tumour promotion [4] , skin irritancy [5, 6] , protein kinase C (PKC) activation [7, 8] , VCAM-1 inhibition [9] , nerve growth factor promotion [10] , as well as pro-in£ammatory [4, 11] , molluscicide [12] , and antiviral activities [13] have also been documented for ingenoids, testifying to the relevance of this class of diterpenoids for biomedical research. A pleiotropic pattern of activity is not uncommon for tumour promoters. Nevertheless, a clear separation between co-cancerogenic and clinically useful activities has been observed for ingenoids [13, 14] , validating the parent polyol as a versatile template for the induction/modulation of bioactivity. Not unexpectedly, ingenol has also received constant attention within the synthetic community [15] , although its total synthesis is yet to be achieved.
Ingenol esters can display both co-carcinogenic and antitumour activity [16] , and IDB, the archetypal antitumour ingenoid, can indeed activate responses mediated by PKC [7, 8, 17] , the main target of tumour-promoting phorboid esters. However, while IDB shows in£ammatory activity comparable to that of phorbol esters, it only retains a marginal fraction of their tumour-promoting activity [7] , and similar di¡erences were observed in other pairs of ingenol 3-and 3,20-diesters [7] . The mechanism underlying this paradoxical behaviour is largely unknown, as are the critical structural features responsible for the dissection of the co-carcinogenic and the antitumour activities. These ¢ndings underscore our limited knowledge of the ingenoid pharmacophore, while the cell type-dependent role of PKC adds an additional layer of complexity to this issue. Thus, while IDB induces apoptosis in thymocytes through a PKC-independent pathway [17] , PKC activation by phorbol esters is crucial to activate the apoptotic machinery in other cell types [18] .
PKC consists of several subfamilies of serine/threoninespeci¢c protein kinases [19] , Ca 2 -dependent classical PKC (cPKC : K, L 1 , L 2 and Q), Ca 2 -independent novel PKC (nPKC: N, O, R and a) and atypical PKC (aPKC: M, S, h), which play a central role in signal transduction in eukaryotes [20^22] . Some of their molecular targets are transcription factors which regulate gene expression, such as the activator protein-1 (AP-1) and the nuclear factor UB (NF-UB), both involved in the regulation of cell proliferation and apoptosis [23, 24] .
The evaluation of IDB analogues modi¢ed at C-20 has shown that cytotoxicity and PKC activation can be dissected [25] , and similar results were reported regarding the anti-HIV activity and PKC activation properties of phorbol esters [26] . These ¢ndings have rekindled interest in phorboids as drug leads, encouraging mechanistic studies on their anticancer and apoptotic activities. We report here that di¡erent pathways, critically dependent on the oxygenation pattern at C-5 and C-20, mediate the apoptotic and PKC-activating properties of IDB.
Results

Ingenol 20-benzoates induce apoptosis in Jurkat cells
The polyhydroxylated southern region plays a key role in the biological activity of ingenoids [25, 33, 34] . The apoptotic activity of the parent polyol (1), IDB (2), and analogues variously substituted at C-3, C-5 and C-20 (compounds 3^7, Fig. 1 ) was investigated in the leukaemia Jurkat cell line. The cells were incubated with 10 WM concentration of each compound for 48 h, and the hypodiploidy (i.e., loss of fragmented DNA) was detected, using propidium iodide (PI) staining as a marker for apoptosis. shows that only 2 and 3 were able to induce a strong increase in the percentage of hypodiploid cells (61.3% and 71.3% respectively). Within the series investigated, these are the only compounds where the 20-hydroxyl is benzoylated. The apoptosis induced by these two compounds was dose-dependent, and concentrations ranging from 0.1 to 30 WM mediated a progressive increase in the percentage of subdiploid cells after 24 h of culture. In contrast, ingenol itself (1) did not induce signi¢cant apoptosis even at the higher doses (Fig. 2B) . Since apoptosis can also be detected after 24 h of treatment, doses of 10 WM and 24 h treatment were generally used throughout.
Apoptosis induced by IDB in Jurkat cells is mediated
by caspase-3 activation and occurs mainly at the S phase of the cell cycle
The caspase family consists of postaspartate-cleaving cysteine proteases which have been shown to be required for apoptosis in a number of experimental systems [35, 36] . To establish the involvement of caspases in IDB-mediated apoptosis of Jurkat cells, we preincubated the cells with the tetrapeptide caspase inhibitors Ac-DEVD-cmk or Z-YVAD-cmk before IDB treatment. Z-YVAD-cmk, which was reported to speci¢cally inhibit caspase-1 and related enzymes, had a limited e¡ect on the increase in the per- centage of subdiploid cells induced by IDB (10 WM). In contrast, the same dose of Ac-DEVD-cmk, which is more speci¢c for the inhibition of caspase-3, a member of the CED-3 subfamily of caspases, was an e¡ective inhibitor of apoptosis induced by IDB.
The involvement of cell cycle control in apoptosis induced by IDB in Jurkat cells was studied by double staining with PI and FITC-4-deoxy-2-uridine triphosphate (FITC-dUTP) as described in Section 5. This gives information on the cell cycle phase where DNA fragmentation occurs. Fig. 3B shows that most DNA fragmentation was detected in the S phase of the cell cycle in Jurkat cells treated for 24 h with IDB at 10 WM concentration. A small but signi¢cant percentage of cells undergoing DNA fragmentation at both G 0 /G 1 and M phases of the cell cycle was also detected.
Activation of the AP-1 and NF-UB transcription factors by ingenol and its esters
In order to study the role of ingenoids in the activation of PKC-inducible transcriptions factors, we stimulated Jurkat cells with IDB (10 WM) for 3 h and nuclear extract was obtained and analysed by electrophoretic mobility shift assay (EMSA) using an AP-1-speci¢c 32 P-labelled oligonucleotide. In Fig. 4A we show that IDB increased the binding of AP-1 to DNA and that it was completely abolished by a 100-fold concentration of cold AP-1 oligonucleotide in the binding reaction, but not by the presence of irrelevant oligonucleotides (NF-UB and SP-1). Next, we stimulated Jurkat cells either with phorbol myristate acetate (PMA, 50 ng/ml) or with increasing doses of ingenols 1, IDB, 3, 5 and 6 for 3 h as indicated, and nuclear extracts were obtained and analysed by EMSA. As shown in Fig. 4B , although to a di¡erent extent, all compounds increased the AP-1 binding to DNA. To correlate these results with transcriptional activities, Jurkat and HeLa cells were transiently co-transfected with equimolar concentrations of both RSV-L-Gal and AP-1-Luc plasmids. Twenty-four hours after transfection, cells were treated with PMA or ingenols 1 and IDB for 6 h, and transactivation was determined and expressed as fold induction. Fig. 4C shows that both compounds were e¡ective in the induction of AP-1 transactivation in both cell lines, IDB being more potent than the parent polyol, as expected from the binding data. In order to evaluate whether another inducible transcription factor had also been activated by ingenols, we carried out kinetics experiments in Jurkat cells stimulated with either IDB, ingenol 1 or ingenol 5 (10 WM each), and in Fig. 5A it is shown that all ingenols tested induced an increase in the binding of NF-UB in nuclear extracts from stimulated Jurkat cells. The speci¢city of the binding was studied by supershift and cold competition experiments, and we identi¢ed that the heterodimer p50/p65 is the main complex activated by ingenols in Jurkat cells. The NF-UB binding results correlate well with the transactivation experiments performed in HeLa cells, where we found that IDB was more potent than either ingenol 1 or 5 to transactivate the KBF-Luc reporter plasmid (Fig. 5B) . Altogether, these results show that both pro-apoptotic and non-apoptotic ingenoids can activate the AP-1 and the NF-UB transcription factors.
PKC is not involved in the apoptotic activity of IDB
IDB can activate several isoforms of PKC in both lymphoid and non-lymphoid cells [8,17^18] . Thus, to study whether this enzyme is involved in NF-UB activation and apoptosis, we transfected HeLa cells with the KBF-Luc plasmid. Twenty-four hours after transfection, the cells were stimulated for 6 h with PMA (10 ng/ml), ingenol (1) (10 WM) or IDB (10 WM) in the presence or absence of GF109203X (0.01 WM), a non-isoform-selective PKC inhibitor [37] . GF109203X completely inhibited NF-UB transactivation induced by PMA, ingenol and IDB (Fig.  6A) . Similarly, this inhibitor prevented the binding of NF-UB to DNA in Jurkat cells stimulated with IDB (10 WM) for 90 min (Fig. 6B) .
Next, we studied if the inhibition of PKC by GF109203X could a¡ect the apoptosis induced by IDB in Jurkat cells. Fig. 6C shows that apoptosis induced by IDB was not mediated by PKC activation, since the PKC inhibitor did not reduce the percentage of hypodiploid cells observed after 18 h stimulation with a pro-apoptotic concentration of IDB; rather, it increased the apoptosis induced by IDB.
Activation of NF-UB and AP-1 by ingenoids requires a free hydroxyl at C-5
In our set of ingenoids, modi¢cations of the 20-hydroxyl do not a¡ect the capacity to activate NF-UB and AP-1 transcription factors. On the other hand, the apoptotic activity depends on the modi¢cation of this position, since only 2 (IDB) and 3 are pro-apoptotic. To investigate the role of the 5-hydroxyl on the transcriptional activities of ingenoids, the non-apoptotic compound 7, where the 5-hydroxyl is esteri¢ed with benzoic acid and the 20-hydroxyl is replaced by a £uorine to prevent acylotropic migration from the 5-to the 20-hydroxyl, was investigated. Thus, Jurkat cells were stimulated with either PMA or increasing doses of 7 for 3 h, and nuclear extracts studied for DNA binding of NF-UB and AP-1. Fig. 7A shows that, unlike its 5-debenzoyl derivative, 7 does not activate NF-UB binding and it is a very weak activator of AP-1. To compare the lack of binding of NF-UB and AP-1 with the transcriptional activity, the e¡ect of the selected compounds was investigated in the K562-AIM cell line, which contains the luciferase gene driven by the activation immediate marker (AIM/CD69) gene promoter stably transfected [38] . This promoter is highly responsive to NF-UB and AP-1 transcription factors [38] . Thus, K562-AIM cells were stimulated with either PMA (10 ng/ml), ingenol 3, IDB (2) or ingenol 7 (10 WM) for 6 h, and we measured the luciferase activity as described above. As expected, IDB and 3 were as e¡ective as PMA to transactivate the AIM promoter, while 7 was practically inactive in this assay. Taken together, these results suggest that the 5-hydroxyl is critical for PKC activation by IDB and its analogues.
Hydroxylation at C-3 and C-4 is not required for apoptosis and NF-UB activation
The esteri¢cation of the 3-hydroxyl with lipophilic acids is essential for tumour promotion by ingenol esters. To evaluate the role of the hydroxyl groups at C-3 and C-4 in the apoptotic activity, the cyclic carbonate 8 and thiocarbonate 9 were synthesised (Fig. 1) . Jurkat cells were treated with these compounds (10 WM) for 24 h and the induction of apoptosis determined by £ow cytometry. Fig.  8A shows that both ingenols induce apoptosis in Jurkat cells to a similar extent, as measured by the percentage of hypodiploid cells (33.6 vs. 37.8%, respectively). Moreover, when NF-UB activation was evaluated in transiently transfected HeLa cells, both compounds were equally potent to activate the NF-UB reported gene (Fig. 8B) . These results reinforce the hypothesis that benzoylation at position C-20 is required for ingenol-induced apoptosis. 
Discussion
Despite the variety of biological end-points of ingenoids, clear structure^activity relationships have emerged only as regards tumour promotion, which requires the presence of a lipophilic ester group at C-3 and a free hydroxyl at C-20 [11] . A binding model based on a three-fold interaction with PKC mediated by the 3-ester carbonyl, the 9-keto group, and the 20-hydroxyl has emerged [39, 40] . However, the biological activity of the parent polyol and that of several 3,20-diesters suggests that alternative ¢ts to PKC exist [4] , while large di¡erences in binding between simpli¢ed analogues and the natural derivatives [41] underscore the relevance of structural elements di¡erent from those highlighted by the postulated pharmacophore for PKC interaction.
Within the set of compounds investigated, only those bearing a benzoate at C-20 (compounds 2, 3, 8, 9) could induce apoptosis in Jurkat cells. The lack of activity of ingenol 3-benzoate (4) showed that the induction of apoptosis by IDB could not be mediated by enzymatic loss of the 20-ester group, which would generate an inactive compound. Moreover, the activity of IDB, ingenol 20-benzoate (3), ingenol 3,4-carbonate 20-benzoate (8) , and ingenol 3,4-thiocarbonate 20-benzoate (9) shows that the induction of apoptosis is relatively insensitive to changes at C-3, a substantial and dramatic deviation from the tumour-promotion pharmacophore.
Deviation from the tumour-promotion pharmacophore was also evidenced as regards PKC-mediated NF-UB and AP-1 activation. Although we have not measured directly the translocation and activation of nPKC, the activation of both transcription factors through nPKC has been documented. Thus, in the AP-1 binding assays the 20-deoxy-20-£uoro derivatives 5 and 6 showed an activity comparable to that of their corresponding hydroxylated compounds (1 and 4, respectively) , while the 20-esters 2 and 3 were active, as were 8 and 9, where the 3-hydroxyl was part of a carbonate (8) or a thiocarbonate ring (9) . Interestingly, benzoylation of the 5-hydroxyl of the 20-deoxy-20-£uoro derivative 7 led to a dramatic decrease of activity, suggesting that the 5-hydroxyl is critical for PKC binding underlying both AP-1 and NF-UB activation.
The a¤nity of IDB for PKC was quanti¢ed by inhibition of [ 3 H]PDBU binding to PKC-K, which only showed a modest activity [41] . To explain the exceedingly high in£ammatory activity of this compound, in vivo enzymatic hydrolysis to the corresponding 3-monobenzoate, a highly irritant activator of cPKC, was suggested [41] . However, the lack of evidence for the in vivo hydrolysis of the 20-ester group, the di¡erent pro¢le of tumour-promoting activity of IDB and ingenol-3-benzoate, as well as recent data from the study of calcium-independent induction of apoptosis in thymocytes [17] , suggested that IDB targets those PKC isoforms di¡erent from cPKC isoforms. Thus, IDB was identi¢ed as a selective activator of PKC-O, although further studies have demonstrated that IDB can interact with almost all isoforms of novel PKC [17] . Since these nPKCs do not require calcium for activation, the observation that neither IDB nor ingenol 3-benzoate mobilises calcium intracellularly (data not shown) further supports the view that non-classical PKCs mediate the activation of NF-UB and AP-1 transcription factors by these compounds.
Apoptosis induced by ingenoid 20-benzoate depends on the activation of caspase-3, and occurs mainly at the S phase of the cell cycle. The discovery of di¡erent structure^activity relationships for apoptotic and PKC-mediated responses suggests that the two processes are mechanistically distinct. In accordance with this, the PKC inhibitor GF109203X does not reduce hypodiploidy induced by IDB; rather, it increased the apoptosis induced by IDB, showing that PKC activation may be involved in the anti-apoptotic activity. This is consistent with the fact that PKC activation in Jurkat cells makes them resistant to apoptosis induced by the death receptor FAS [42] . Thus, depending on the cell type, non-apoptotic PKCbinding ingenoids can behave as tumour promoters in at least two ways: either by activating a set of PKC-dependent genes involved in cellular growth and di¡erentiation, or, alternatively, by rendering the cells resistant to apoptosis mediated by the death receptor Fas/APO-1 and by NF-UB-dependent anti-apoptotic genes [43^45].
Phorboid-containing plants have been used to treat tumours for centuries [1] , and PMA, the archetypal tumourpromoting phorboid, has been clinically investigated as an anticancer agent [46] . It is therefore ironic that most studies on these essential probes for cell biology have been focused instead on their skin-irritant and tumour-promoting activities. The discovery that the apoptotic and the PKC-activating properties of IDB are mediated by di¡er-ent pathways and governed by distinct structure^activity relationships should foster investigations aimed at a better mechanistic understanding of the anticancer potential of phorboids. In this context, the identi¢cation of the molecular targets underlying their antitumour activity and the dissection of anticancer and PKC-mediated activities by suitable structural modi¢cations will be essential to obtain non-pleiotropic drug candidates amenable to pharmaceutical development.
Signi¢cance
Ingenoids are a structurally diverse class of diterpenes endowed with a pleiotropic pattern of biological activity and paradoxical tumour-promoting and anticancer properties. The polyhydroxylated southern region has a key role in the biological activity of these compounds, and we have developed a structure^activity relationship model to evaluate the apoptotic and the non-apoptotic properties of ingenoids. The induction of apoptosis and the activation of the PKC-dependent transcription factors NF-UB and AP-1 turned out to be mediated by di¡erent signal pathways. Esteri¢cation of the 20-hydroxyl was required to induce apoptosis, while a free 5-hydroxyl was critical for PKC activation, evidencing signi¢cant deviations from the tumour-promotion pharmacophore for both activities. The ¢nding that the apoptotic and the PKC-activating properties of IDB are mediated by di¡erent pathways and governed by distinct structure^activity relationships validates ingenol as a lead structure to develop new anticancer drugs.
Materials and methods
Cell lines and reagents
Jurkat cells (ATCC, Rockville, MD, USA) were maintained in exponential growth in RPMI 840 medium (Bio-Whittaker, Verviers, Belgium) and the cervix cancer HeLa cells (ATCC) in Dulbecco's modi¢ed Eagle's medium (Bio-Whittaker). The culture media were supplemented with 10% heat-inactivated foetal calf serum, 2 mM L-glutamine and the antibiotics penicillin and strep- tomycin (Gibco, Paisley, UK). K562-AIM cells were maintained in complete RPMI medium containing G418 (100 Wg/ml).
[Q-
32 P]ATP (3000 Ci/mM) was purchased from ICN (Costa Mesa, CA, USA). The cell-permeable inhibitors of caspase-1 (Z-YVAD-cmk) and caspase-3 (Ac-DEVD-cmk) were from Bachem (Switzerland). FITC-dUTP and terminal deoxynucleotide transferase (TdT) were from Boehringer Mannheim (Germany). The PKC inhibitor GF109203X was from Biomol (Plymouth Meeting, PA, USA). All other reagents not cited above or later were from Sigma Chemical Co. (Barcelona, Spain). Ingenol was obtained from the seeds of the caper spurge [27] .
Synthesis of ingenoids
Compounds 2^7 are known, and were prepared according to literature procedures [25, 28] . Compounds 8 and 9 were synthesised as follows (synthesis of 8 as representative): they were added to a cooled (0³C) solution of ingenol 5,20-acetonide [28] (100 mg, 1.26 mM) in dry CH 2 Cl 2 (10 ml), pyridine (5 ml) and excess phosgene (1.0 ml of a 20% toluene solution, 10 mM, 38 mol. equiv.). After being stirred at 0³C for 30 min the reaction was worked up by dilution with hexane^ether (3:1, 100 ml) and sequential washing with water and brine. Removal of the solvent gave the crude 3,4-carbonate 5,20-acetonide, which was taken up in 10 ml of 10 33 M methanolic HClO 4 . After being stirred for 45 min at room temperature, the reaction was worked up by the addition of sat. aq. NaHCO 3 , concentration at reduced pressure and partition between water and EtOAc. The organic phase was washed with brine, dried (MgSO 4 ) and evaporated, to give ingenol 3,4-carbonate as a colourless foam. For the selective benzoylation, the latter was dissolved in dry CH 2 Cl 2 (1 ml), and the cooled (318³C) solution was treated with N-3-dimethylaminopropyl-NP-ethylcarbodiimide hydrochloride (EDC, 74 mg, 0.39 mM), 4-dimethylaminopyridine (DMAP, 47 mg, 0.39 mM), and benzoic acid (47 mg, 0.39 mM). The solution was stirred at 318³C overnight and worked up by dilution with EtOAc and sequential washing with 5% NaOH, water, and brine. After removing the solvent, the crude product was puri¢ed by column chromatography on silica gel (hexane^EtOAc 9:1 as eluant) to give 66 mg (53% from ingenol 5,20-acetonide) 8 as a colourless amorphous foam. 
Determination of nuclear DNA loss and cell cycle analysis
The percentage of cells undergoing chromatinolysis (subdiploid cells) was determined by ethanol ¢xation (70%, for 24 h at 4³C). Then, the cells were washed twice with phosphate-bu¡ered saline (PBS) containing 4% glucose and subjected to RNA digestion (RNase A, 50 U/ml) and PI (20 Wg/ml) staining in PBS for 1 h at room temperature. The cell cycle was analysed by cyto£uori-metry as previously described [29] . With this method, low molecular weight DNA leaks from the ethanol-¢xed apoptotic cells and the subsequent staining make it possible to determine the percentage of subdiploid cells (sub-G 0 /G 1 fraction).
Detection of DNA strand breaks by the TUNEL method
The percentage of apoptotic cells was alternatively measured by the TUNEL method as previously described, with minor modi¢cations. Brie£y, cells (1U10 6 ) were ¢xed in 4% paraformaldehyde in PBS for 24 h at 4³C, washed twice in PBS and permeabilised in 0.1% sodium citrate containing 0.1% Triton X-100 for 2 min. Fixed cells were washed three times in PBS and resuspended in a ¢nal volume of 50 Wl of TUNEL bu¡er (0.3 nmol FITC-dUTP, 3 nmol dATP, 50 nmol CoCl 2 , 5 U TdT, 200 mM potassium cacodylate, 250 Wg/ml bovine serum albumin (BSA) and 25 mM Tris^HCl pH 6.6). The cells were incubated for 1 h at 37³C and then washed twice in PBS and analysed by £ow cytometry. To determine both the DNA strand breaks and the cell cycle, TUNEL-stained cells were counterstained with PI and treated with RNase as described above prior to cyto£uorimetric analysis. In this method, ¢xation in formaldehyde prevents the leaking of low molecular weight DNA from apoptotic cells, and thus the cell cycle distribution estimates both apoptotic and nonapoptotic cells [30] .
Isolation of nuclear extracts and mobility shift assays
Jurkat cells were cultured at 2U10 6 /ml and stimulated with the agonists in complete medium as indicated. Cells were then washed twice with cold PBS and proteins from nuclear extracts isolated as previously described [31] . Protein concentration was determined by the Bradford method (Bio-Rad, Richmond, CA, USA). For the EMSA assay, the consensus oligonucleotide probes:
NF-UB, 5P-AGTTGAGGGGACTTTCCCAGG-3P ; AP-1, 5P-CGCTTGATGAGTCAGCCGGAA-3P, were labelled with [Q-32 P]ATP (Amersham, Freiburg Germany). The binding reaction mixture contained 3 Wg of nuclear extract, 0.5 Wg poly-(dI-dC) (Pharmacia Fine Chemical, Piscataway, NJ, USA), 20 mM HEPES pH 7, 70 mM NaCl, 2 mM dithiothreitol (DTT), 0.01% NP-40, 100 Wg/ml BSA, 4% Ficoll, and 100 000 cpm of end-labelled DNA fragments in a total volume of 20 Wl. When indicated, 0.5 Wl of rabbit anti-p50, anti-p65 or preimmune serum [32] was added to the standard reaction before the addition of the radiolabelled probe. Dr. Alain Israe «l (Institut Pasteur, France) kindly provided the anti-NF-UB sera. For cold competition, a 100-fold excess of the double-stranded oligonucleotide competitor was added to the binding reaction. After 30 min incubation at 4³C, the mixture was electrophoresed through a native 6% polyacrylamide gel containing 89 mM Tris^borate, 89 mM boric acid and 1 mM EDTA. Gels were pre-electrophoresed for 30 min at 225 V and then for 2 h after loading the samples. These gels were dried and exposed to XAR ¢lm at 380³C.
Transient transfections and luciferase activity
HeLa (10 5 /ml) or Jurkat cells (2U10 6 /ml) were transiently transfected using either the lipofectamine reagent (Life Technologies, Madrid, Spain) or the Superfect reagent (Qiagen, Germany) respectively, according to the manufacturer's recommendations. To determine AP-1-dependent transcription, Jurkat or HeLa cells were transfected with the AP-1-Luc reporter plasmid (0.5 Wg/ml) which was constructed by inserting three copies of an SV40 AP-1 binding site into the Xho site of pGL-2 promoter vector (Promega, Madison, WI, USA), and to determine NF-UB-dependent transcription, HeLa cells were transfected with the KBF-Luc (0.5 Wg/ml) reporter plasmid which contains three copies of an NF-UB binding site (from the MHC promoter) fused to a minimal SV40 promoter driving luciferase [32] . Twenty-four hours after transfection the cells were stimulated with the indicated agonists for 6 h and then lysed in 25 mM Tris^phosphate pH 7.8, 8 mM MgCl 2 , 1 mM DTT, 1% Triton X-100, and 7% glycerol. Luciferase activity was measured in a luminometer (Lumat Berthold, USA) following the instructions of the luciferase assay kit (Promega). The background obtained with the lysis bu¡er was subtracted in each experimental value. All the experiments were repeated at least three times. Transfection e¤ciencies were normalised by co-transfection with the L-galactosidase expression plasmid RSV-L-galactosidase, and L-galactosidase levels were determined using a commercial kit (Promega).
